Among these enzymes and proteins, Acca, glyA, glyQ, eno, pgk, and por were identified in our previous study as associated with precancerous anal lesions, highlighting their roles as metabolic markers in cancer progression (10). This evidence concerns the gene PRKG1 and cancer.